It was this common belief and passion for research to uncover new knowledge and improve healthcare that led them to carry out Adherence Testing Using Urine Mass Spectrometry (ADURINE) in Singapore. Leveraging mass spectrometry to detect medication compounds in urine samples, the technology provides objective evidence of whether patients are actually taking their prescribed medications.
Dr Sumitro explains how this transforms patient interactions, "We can have frank conversations with patients – 'Aunty, you haven't been taking the medication, right? Can you tell me why? Is it because this medicine is giving you problems?' Then we can explore solutions – combination tablets, different dosages, addressing specific concerns."
This represents a fundamental shift to medication non-adherence, enabling honest, supportive discussions that address real barriers to treatment compliance.
It is exactly this kind of meaningful change that drives their research forward. As their ADURINE research continues to gather data, both doctors remain focused on the ultimate goal: bridging the gap between clinical challenges and innovative solutions and turning difficult conversations into opportunities for genuine partnership with patients – one honest conversation at a time.
Learn more about Dr Sumitro's journey and what inspires him here.